We are live on ! Find out more
DY

Dowling & Yahnke Portfolio holdings

AUM $2.15B
1-Year Est. Return 10.82%
This Fund
S&P 500
This Quarter Est. Return
+6.63%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
AUM
$1.74B
AUM Growth
+$276M
Cap. Flow
+$178M
Cap. Flow %
10.22%
Top 10 Hldgs %
26.57%
Holding
376
New
39
Increased
143
Reduced
134
Closed
9

Sector Composition

Rank Sector Weight
1 Miscellaneous 31.47%
2 Technology 15.8%
3 Financials 10.71%
4 Healthcare 10.19%
5 Consumer Staples 7.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GWPH
376
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
-8,409
Closed -$1.82M

Similar funds

Dowling & Yahnke's Q2 2021 Portfolio in Review

As of Q2 2021, Dowling & Yahnke held 376 positions worth $1.74B, up 19% from $1.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Dowling & Yahnke deployed $178M of net new capital in Q2 2021, opening 39 new positions and adding to 143 existing holdings. Its largest new stake was Dimensional US Equity ETF: 1,143,816 shares worth $53.9M.

By sector, the portfolio is most concentrated in Miscellaneous at 31% of assets, up from 25% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Bank of America, an estimated $1.93M trimmed.

  • Dowling & Yahnke's largest Q2 2021 buy was Dimensional US Equity ETF: 1,143,816 shares worth $53.9M.
  • Dowling & Yahnke added most to Vanguard S&P 500 ETF in Q2 2021, an estimated $5.26M increase.
  • Dowling & Yahnke's biggest Q2 2021 reduction was Bank of America, cutting an estimated $1.93M.
  • Dowling & Yahnke fully exited GW Pharmaceuticals Plc American Depositary Shares in Q2 2021, selling an estimated $1.82M.
  • Dowling & Yahnke's ten largest holdings make up 27% of its $1.74B portfolio in Q2 2021.
  • Dowling & Yahnke opened 39 new positions and closed 9 in Q2 2021.
  • Dowling & Yahnke's portfolio value rose 19% quarter-over-quarter to $1.74B.

Based on Dowling & Yahnke's 13F filing for Q2 2021, filed 21 Jul 2021.